REGENTIS BIOMATERIALS LTD. (RGNT)
$1.99-$0.06 (-2.91%) Today
Efraim Cohen-Arazi - DirectorRegentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 8 | 176,193 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
6 Form 4 filings on record, the earliest from Jul 13, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Susan Phd Md Alpert - Director | Grant or award | Employee Stock Option (Right to Buy) | 24,826 | $0.00 | - | |
| Pini Ben-Elazar - Director | Grant or award | Employee Stock Option (Right to Buy) | 24,826 | $0.00 | - | |
| Pini Ben-Elazar - Director | Grant or award | Employee Stock Option (Right to Buy) | 8,313 | $0.00 | - | |
| Keith Valentine - Director | Grant or award | Employee Stock Option (Right to Buy) | 24,826 | $0.00 | - | |
| Jeff Dykan - Director | Grant or award | Warrants to purchase ordinary shares | 12,500 | $0.00 | - | |
| Jeff Dykan - Director | Grant or award | Employee Stock Option (Right to Buy) | 24,826 | $0.00 | - | |
| Ehud Geller - Officer | Grant or award | Warrants to purchase ordinary shares | 31,250 | $0.00 | - | |
| Efraim Cohen-Arazi - Director | Grant or award | Employee Stock Option (Right to Buy) | 24,826 | $0.00 | - |
REGENTIS BIOMATERIALS LTD. (RGNT) had 6 insider filings in the last 90 days, with the most recent on 2026-07-13. The full record for RGNT runs to 6 Form 4 filings, the earliest from 2026-07-13. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of RGNT were filed in the last 90 days.
No insider sales of RGNT were filed in the last 90 days.
This page tracks RGNT Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add RGNT to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
$RGTROYCE GLOBAL TRUST, INC.
$RHIROBERT HALF INC.
$RIAEXRBC BlueBay Enhanced Income Fund
$RIKURIKU DINING GROUP Ltd
$RILAJackson National Life Insurance Co
$RIMEAlgorhythm Holdings, Inc.
$RITEMINERALRITE Corp
$RIVRIVERNORTH OPPORTUNITIES FUND, INC.
$RKAMROKIT America, Inc.
$RKMIXRockefeller Municipal Opportunities FundEvery Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.